Identity
- Trade Name
- BBIG FDA UDI
- Generic Name
- Spectacle frame FDA UDI
- Device Name
- TR8003905 FDA UDI
- Model / Reference
- TR8003905 FDA UDI
- Description
- TR8003905 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 08719616039428 FDA UDI
- FDA Product Code
- HQZ FDA UDI
- GMDN Term
- Spectacle frame FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 886.5842 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Spectacle frame
A comprehensive medical device designed to hold a pair of spectacle lenses in front of and close to the eyes of the user. It is typically made of plastic or metallic frame, supported by the nose and ears, and may have a protective function.
Similar devices
Also classified as Spectacle frame.
- Fielmann — Fielmann Group AG · Class I
- Fysh — WestGroupe Optical Inc · Class I
- Kliik:denmark Eyewear — WestGroupe Optical Inc · Class I
- Fielmann — Fielmann Group AG · Class I
- EYEWEAR BY ROI WOODBURY BROWN — Eyewear By Roi, Limited · Class I
- Daniel Hechter — MPG GmbH · Class I
- Kazuo Kawasaki — MASUNAGA OPTICAL MFG.CO., LTD. · Class I
- Superflex Kids Collection — WestGroupe Optical Inc · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- BBig B.V.
Sources (1)
- FDA UDI 95af9ccc-e1bc-4374-929b-7d797198da19 33 fields · synced Jul 24, 2026